Profile data is unavailable for this security.
About the company
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
- Revenue in USD (TTM)976.52k
- Net income in USD-32.42m
- Incorporated1998
- Employees110.00
- LocationVolitionRX Ltd1489 West Warm Springs Road, Suite 110HENDERSON 89014United StatesUSA
- Phone+1 (646) 650-1351
- Fax+65 6333-7235
- Websitehttps://volition.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Syros Pharmaceuticals Inc | 4.15m | -131.56m | 53.08m | 68.00 | -- | -- | -- | 12.80 | -4.30 | -4.30 | 0.1222 | -0.2369 | 0.0288 | -- | -- | 61,000.00 | -91.46 | -54.44 | -112.06 | -64.32 | -- | -- | -3,171.70 | -772.82 | -- | -- | 1.18 | -- | -33.23 | 37.12 | -73.87 | -- | -27.78 | -- |
| Serina Therapeutics Inc | 179.00k | -18.67m | 53.38m | 4.00 | -- | -- | -- | 298.20 | -9.72 | -9.72 | 0.0403 | -1.86 | 0.0156 | -- | 6.28 | 44,750.00 | -162.58 | -194.46 | -- | -- | 49.72 | 85.80 | -10,438.55 | -2,347.36 | -- | -1.82 | -- | -- | 317.65 | -36.69 | -41.49 | -- | -- | -- |
| Angion Biomedica Corp | 0.00 | -38.66m | 54.84m | 32.00 | -- | -- | -- | -- | -4.83 | -4.83 | 0.00 | -0.161 | 0.00 | -- | -- | 0.00 | -144.89 | -105.91 | -202.49 | -331.69 | -- | -- | -- | -712.81 | -- | -- | -- | -- | -100.00 | -- | 9.31 | -- | -- | -- |
| Aerovate Therapeutics Inc | 0.00 | -87.94m | 55.14m | 51.00 | -- | 0.5838 | -- | -- | -3.14 | -3.14 | 0.00 | 3.27 | 0.00 | -- | -- | 0.00 | -65.76 | -- | -74.16 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -46.61 | -- | -- | -- |
| Prenetics Global Ltd | 22.25m | -49.97m | 55.28m | 320.00 | -- | 0.2413 | -- | 2.48 | -4.33 | -5.32 | 1.91 | 18.75 | 0.0832 | 3.89 | 4.53 | 69,535.41 | -19.43 | -- | -23.55 | -- | 45.56 | -- | -233.41 | -- | 2.25 | -5.17 | 0.0086 | -- | 65.17 | -- | 75.91 | -- | -- | -- |
| Actinium Pharmaceuticals Inc | 81.00k | -42.62m | 55.45m | 49.00 | -- | 1.24 | -- | 684.63 | -1.52 | -1.52 | 0.0029 | 1.43 | 0.0009 | -- | -- | 1,653.06 | -45.12 | -46.98 | -50.13 | -52.71 | -- | -- | -52,620.99 | -6,683.95 | -- | -- | 0.0006 | -- | -92.14 | -- | -47.86 | -- | 9.75 | -- |
| Kronos Bio Inc | 8.41m | -102.85m | 55.48m | 58.00 | -- | 0.4503 | -- | 6.60 | -1.75 | -1.75 | 0.1425 | 2.04 | 0.0396 | -- | -- | 135,661.30 | -48.41 | -35.47 | -53.26 | -37.14 | -- | -- | -1,222.83 | -7,975.76 | -- | -- | 0.00 | -- | -- | -- | 15.41 | -- | -8.78 | -- |
| Hookipa Pharma Inc | 52.16m | -48.60m | 55.69m | 151.00 | -- | 0.6471 | -- | 1.07 | -5.28 | -5.28 | 4.85 | 7.14 | 0.33 | -- | 309.57 | 345,450.30 | -30.74 | -41.63 | -40.15 | -50.26 | -- | -- | -93.16 | -366.65 | -- | -- | 0.00 | -- | 41.27 | 21.41 | -25.67 | -- | 14.11 | -- |
| Celularity Inc | 22.77m | -196.30m | 56.28m | 120.00 | -- | 1.21 | -- | 2.47 | -11.29 | -11.29 | 1.30 | 2.11 | 0.0836 | 2.90 | 2.39 | 189,758.30 | -72.04 | -19.19 | -94.47 | -20.99 | 29.66 | -- | -862.04 | -454.79 | 0.2086 | 1.37 | 0.4893 | -- | 26.68 | -- | -1,483.14 | -- | -- | -- |
| VolitionRX Ltd | 976.52k | -32.42m | 56.57m | 110.00 | -- | -- | -- | 57.93 | -0.4032 | -0.4032 | 0.0121 | -0.263 | 0.0481 | -- | 5.38 | 8,877.45 | -161.39 | -111.92 | -- | -196.20 | -- | -- | -3,357.34 | -10,793.31 | -- | -129.66 | -- | -- | 153.04 | -- | -16.68 | -- | 29.13 | -- |
| Enzo Biochem Inc | 33.34m | -17.55m | 57.12m | 179.00 | -- | 0.8237 | -- | 1.71 | -0.3516 | 0.9194 | 0.6633 | 1.35 | 0.4028 | 1.66 | 4.91 | 186,257.00 | -21.20 | -12.21 | -34.50 | -15.79 | 43.66 | 37.09 | -52.63 | -18.76 | 3.16 | -- | 0.053 | -- | -4.85 | -21.01 | -23.02 | -- | 7.89 | -- |
| Aileron Therapeutics Inc | 0.00 | -25.22m | 57.41m | 15.00 | -- | 1.02 | -- | -- | -3.25 | -3.25 | 0.00 | 4.67 | 0.00 | -- | -- | 0.00 | -40.88 | -65.99 | -43.02 | -75.37 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 42.43 | -- | -- | -- |
| Intensity Therapeutics Inc | 0.00 | -15.08m | 57.43m | 5.00 | -- | 10.70 | -- | -- | -1.10 | -1.10 | 0.00 | 0.3898 | 0.00 | -- | -- | 0.00 | -112.08 | -- | -146.09 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -56.45 | -- | -- | -- |
| Champions Oncology Inc | 51.66m | -3.40m | 58.18m | 210.00 | -- | -- | -- | 1.13 | -0.2541 | -0.2541 | 3.78 | -0.0244 | 1.88 | -- | 5.75 | 245,976.20 | -12.39 | -10.00 | -44.43 | -23.00 | 44.27 | 46.58 | -6.58 | -6.04 | -- | -- | 333.00 | -- | -6.90 | 13.13 | -36.38 | -- | 0.0479 | -- |
| Mural Oncology PLC | 0.00 | -173.30m | 58.78m | 117.00 | -- | 0.2855 | -- | -- | -10.35 | -10.35 | 0.00 | 12.09 | 0.00 | -- | -- | 0.00 | -131.01 | -- | -164.28 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -9.29 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to VolitionRX Ltd's reporting currency: US Dollar USD
8.57%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lagoda Investment Management LPas of 30 Jun 2024 | 5.44m | 5.90% |
| Geode Capital Management LLCas of 30 Jun 2024 | 634.55k | 0.69% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 622.95k | 0.68% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 509.47k | 0.55% |
| Bridgeway Capital Management LLCas of 30 Jun 2024 | 174.18k | 0.19% |
| Silverberg Bernstein Capital Management LLCas of 30 Jun 2024 | 144.62k | 0.16% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 123.92k | 0.14% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 2024 | 89.30k | 0.10% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Jun 2024 | 89.23k | 0.10% |
| UBS Securities LLCas of 30 Jun 2024 | 65.27k | 0.07% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
